iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation
Tyrosine hydroxylase deficiency (THD) is a rare genetic disorder leading to dopaminergic depletion and early-onset Parkinsonism. Affected children present with either a severe form that does not respond to L-Dopa treatment (THD-B) or a milder L-Dopa responsive form (THD-A). We generated induced plur...
| Autores: | , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Fundació Sant Joan de Déu |
| Repositorio: | r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| OAI Identifier: | oai:fsjd.fundanetsuite.com:p22872 |
| Acceso en línea: | https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=22872 |
| Access Level: | acceso abierto |
| Palabra clave: | dopamine iPSC L-Dopa Parkinsonism tyrosine hydroxylase deficiency |
| id |
ES_3e211dae4c047f7d4718377d3fb82d2f |
|---|---|
| oai_identifier_str |
oai:fsjd.fundanetsuite.com:p22872 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformationTristán-Noguero AFernández-Carasa ICalatayud CBermejo-Casadesús CPons-Espinal MColini Baldeschi ACampa LArtigas FBortolozzi ADomingo-Jiménez RIbáñez SPineda MArtuch RRaya ÁGarcía-Cazorla ÀConsiglio AdopamineiPSCL-DopaParkinsonismtyrosine hydroxylase deficiencyTyrosine hydroxylase deficiency (THD) is a rare genetic disorder leading to dopaminergic depletion and early-onset Parkinsonism. Affected children present with either a severe form that does not respond to L-Dopa treatment (THD-B) or a milder L-Dopa responsive form (THD-A). We generated induced pluripotent stem cells (iPSCs) from THD patients that were differentiated into dopaminergic neurons (DAn) and compared with control-DAn from healthy individuals and gene-corrected isogenic controls. Consistent with patients, THD iPSC-DAn displayed lower levels of DA metabolites and reduced TH expression, when compared to controls. Moreover, THD iPSC-DAn showed abnormal morphology, including reduced total neurite length and neurite arborization defects, which were not evident in DAn differentiated from control-iPSC. Treatment of THD-iPSC-DAn with L-Dopa rescued the neuronal defects and disease phenotype only in THDA-DAn. Interestingly, L-Dopa treatment at the stage of neuronal precursors could prevent the alterations in THDB-iPSC-DAn, thus suggesting the existence of a critical developmental window in THD. Our iPSC-based model recapitulates THD disease phenotypes and response to treatment, representing a promising tool for investigating pathogenic mechanisms, drug screening, and personalized management.SPRINGERNATURE2023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=22872EMBO Molecular MedicineISSN: 17574676ISSNe: 17574684reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déuinstname:Fundació Sant Joan de DéuInglésinfo:eu-repo/semantics/openAccessoai:fsjd.fundanetsuite.com:p228722026-05-27T12:37:41Z |
| dc.title.none.fl_str_mv |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation |
| title |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation |
| spellingShingle |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation Tristán-Noguero A dopamine iPSC L-Dopa Parkinsonism tyrosine hydroxylase deficiency |
| title_short |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation |
| title_full |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation |
| title_fullStr |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation |
| title_full_unstemmed |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation |
| title_sort |
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation |
| dc.creator.none.fl_str_mv |
Tristán-Noguero A Fernández-Carasa I Calatayud C Bermejo-Casadesús C Pons-Espinal M Colini Baldeschi A Campa L Artigas F Bortolozzi A Domingo-Jiménez R Ibáñez S Pineda M Artuch R Raya Á García-Cazorla À Consiglio A |
| author |
Tristán-Noguero A |
| author_facet |
Tristán-Noguero A Fernández-Carasa I Calatayud C Bermejo-Casadesús C Pons-Espinal M Colini Baldeschi A Campa L Artigas F Bortolozzi A Domingo-Jiménez R Ibáñez S Pineda M Artuch R Raya Á García-Cazorla À Consiglio A |
| author_role |
author |
| author2 |
Fernández-Carasa I Calatayud C Bermejo-Casadesús C Pons-Espinal M Colini Baldeschi A Campa L Artigas F Bortolozzi A Domingo-Jiménez R Ibáñez S Pineda M Artuch R Raya Á García-Cazorla À Consiglio A |
| author2_role |
author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
dopamine iPSC L-Dopa Parkinsonism tyrosine hydroxylase deficiency |
| topic |
dopamine iPSC L-Dopa Parkinsonism tyrosine hydroxylase deficiency |
| description |
Tyrosine hydroxylase deficiency (THD) is a rare genetic disorder leading to dopaminergic depletion and early-onset Parkinsonism. Affected children present with either a severe form that does not respond to L-Dopa treatment (THD-B) or a milder L-Dopa responsive form (THD-A). We generated induced pluripotent stem cells (iPSCs) from THD patients that were differentiated into dopaminergic neurons (DAn) and compared with control-DAn from healthy individuals and gene-corrected isogenic controls. Consistent with patients, THD iPSC-DAn displayed lower levels of DA metabolites and reduced TH expression, when compared to controls. Moreover, THD iPSC-DAn showed abnormal morphology, including reduced total neurite length and neurite arborization defects, which were not evident in DAn differentiated from control-iPSC. Treatment of THD-iPSC-DAn with L-Dopa rescued the neuronal defects and disease phenotype only in THDA-DAn. Interestingly, L-Dopa treatment at the stage of neuronal precursors could prevent the alterations in THDB-iPSC-DAn, thus suggesting the existence of a critical developmental window in THD. Our iPSC-based model recapitulates THD disease phenotypes and response to treatment, representing a promising tool for investigating pathogenic mechanisms, drug screening, and personalized management. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=22872 |
| url |
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=22872 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
SPRINGERNATURE |
| publisher.none.fl_str_mv |
SPRINGERNATURE |
| dc.source.none.fl_str_mv |
EMBO Molecular Medicine ISSN: 17574676 ISSNe: 17574684 reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu instname:Fundació Sant Joan de Déu |
| instname_str |
Fundació Sant Joan de Déu |
| reponame_str |
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| collection |
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869406505792438272 |
| score |
15.811543 |